The DPM2 gene helps your cells place small sugar tags on proteins, which helps many proteins fold properly and do their jobs. This gene plays an important role in growth, brain function, muscle tone, and other body systems that rely on those proteins. If the DPM2 gene does not work properly, it can cause a rare inherited condition with developmental delay, seizures, low muscle tone, and movement or vision problems. The DPM2 gene is not widely known in popular culture.
What is a gene?
Genes are sections of DNA that carry instructions your cells can use to make molecules or regulate processes in the body. Some genes hold the information needed to make proteins, the parts of cells that do the work. Other genes mainly help control when certain processes happen, where they happen, and how strongly they run. Taken together, genes influence how the body develops and functions, and they can also shape how you respond to food, stress, or medications. To explore this topic in more depth, you can find more in the LearnHub.
Overview
DPM2Gene function
What if the gene works
The DPM2 gene helps cells add a sugar called mannose to proteins and some fats. This supports normal protein folding, cell surface attachment, and cell signaling.
Risk
What if the gene does not work
When the DPM2 gene does not work properly, it can cause a congenital glycosylation condition that often affects brain and muscle development. People may have low muscle tone, developmental delay, seizures, or weakness, with severity ranging from mild to life limiting.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the DPM2 gene, no DPM2-specific treatment or drug-selection approach is currently established in clinical guidelines. Care is generally supportive and tailored to the person’s symptoms, while treatments aimed at glycosylation pathways are still being studied rather than used as standard care for DPM2-related conditions.
Conditions associated with DPM2
Gene function
What if the gene works
Inside your cells, the DPM2 gene helps build a small but essential part of the machinery that adds certain sugar pieces to proteins and fats. This matters because these sugar tags help many proteins mature, move to the right place, and work as expected. Understanding what the DPM2 gene does helps explain how cells handle routine protein processing.
The DPM2 gene helps a three-part protein team stay assembled in the endoplasmic reticulum, the cell compartment that processes many proteins. It helps keep this team in the membrane so it can work efficiently.
One of its main roles is to help cells make dolichol phosphate mannose, a molecule that carries mannose, a type of sugar. Cells use this molecule as a sugar source during routine protein and fat processing.
By supporting this sugar supply, the DPM2 gene helps cells add important sugar tags to many newly made proteins and some cell-surface fats. These tags help proteins fold, travel, and settle into the right place.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DPM2 gene can weaken or destabilize a small helper protein in a cell pathway that supplies sugars for protein glycosylation (adding sugars to proteins). This shows how DPM2 gene variants affect protein glycosylation: milder variants may leave some activity, while more severe variants can greatly reduce a key sugar carrier and disrupt GPI anchors, which help hold proteins on the cell surface. In DPM2-related disease, stronger loss of function often tracks with earlier and more marked symptoms.
How variants are linked to conditions
Pathogenic variants in the DPM2 gene cause DPM2-CDG, a rare inherited condition in the congenital disorders of glycosylation group. People with variants in the DPM2 gene linked to this diagnosis may have developmental delay, low muscle tone, seizures, feeding difficulties, and muscle weakness. Reported cases show a wide range of severity, from major medical needs in early life to milder ongoing nerve and muscle symptoms.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For DPM2, risk is mainly shaped by inheritance rather than lifestyle. A child is affected when they inherit nonworking copies of the DPM2 gene from both parents, so family history and parents being blood relatives can raise the chance in a family. There is not enough evidence to say that diet, exercise, or other daily habits change this risk.
Inheritance of DPM2 variants
DPM2-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy of the DPM2 gene from each parent. For families learning how DPM2 gene variants are inherited, parents who each carry one variant are typically unaffected, but with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child without the familial variant. Sons and daughters are affected equally.
What does my DPM2 result mean for my family?
For DPM2, the main recognized condition follows a recessive pattern in families. This usually means parents of an affected child are healthy carriers, and brothers or sisters may also be affected or may be carriers. Other close relatives, such as siblings of the parents, may be carriers too, so the result can matter beyond one person.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the DPM2 gene, a lab can study DNA from a blood sample, saliva, or a cheek swab. Genetic testing for the DPM2 gene usually uses a multigene panel or exome sequencing, which reads the gene’s code and looks for changes that may help explain symptoms or confirm a diagnosis.
When should I consider getting a genetic test?
Testing for the DPM2 gene may be considered if a baby or child has unexplained developmental delay, very low muscle tone, seizures, or other signs of a rare inherited condition linked to this gene. It can also be useful when there is a family history of the condition or a known DPM2 change in a relative.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the type of variant involved. Lifestyle, environment, age, and medical history are among the many factors that shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics is the area of medicine that examines how genetic differences affect the way people respond to medications. It studies connections between genes and drugs to better understand why treatments can work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This knowledge can help support treatment decisions that are more informed and individualized. To explore this subject in more detail, you can learn more in the LearnHub.
Drugs influenced by the DPM2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines work, so questions about side effects, treatment changes, or new symptoms are best discussed with your doctor.
History
In the late 1990s, researchers identified the DPM2 gene while studying how cells build sugar chains needed for many proteins. It was recognized as part of the dolichol phosphate mannose synthase complex, a key step in a process later linked to several inherited metabolic conditions. From these first observations, research expanded steadily, and scientists clarified that DPM2 works closely with other genes in the same pathway, including DPM1 and DPM3. In the years that followed, rare disease studies connected harmful variants in the DPM2 gene with a congenital disorder of glycosylation, helping explain why some affected children shared similar symptoms. These historical steps shaped today’s understanding of DPM2 as a small but important gene in human genetics.